Gelmedix: Funding, Investors & Team (Nov 2026)
Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment.
Gelmedix has raised $400k across 1 funding round on record, the most recent a Seed of $400k announced in Oct 2025.
That round is below the $8.8M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Gelmedix Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Gelmedix Funding Rounds
Gelmedix Founders and Leadership Team
Contact details for the Gelmedix team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Gelmedix Funding Compared to Other Biotechnology Startups
Gelmedix's latest round of $400k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Gelmedix in Biotechnology and Newton
Companies Similar to Gelmedix
Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus…
Zafrens, a pharmaceutical research organization, focuses on designing life sciences solutions for…
Quanta is a biotechnology company uncovering novel cancer therapeutic candidates to target driver oncogenes.…
Arctic Therapeutics specializes in finding the genetic origins of common diseases and creating successful…
100XBIO is creating a cutting-edge platform for analyzing multiple T-cells automatically, aiming to…
MEND is a company focused on life sciences, determined to assist individuals in achieving better health…
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Gelmedix Funding FAQs
What does Gelmedix do?
Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment.
How much funding has Gelmedix raised?
Gelmedix has raised $400k across 1 round on record. The most recent is a Seed of $400k announced in Oct 2025.
When did Gelmedix last raise funding?
Gelmedix's most recent funding round on record is a Seed of $400k, announced in Oct 2025.
Who is the CEO of Gelmedix?
Max Cotler is listed as CEO at Gelmedix.
Where is Gelmedix headquartered?
Gelmedix is based in Newton, United States.
How many employees does Gelmedix have?
Gelmedix is in the 1-10 employee band.
How does Gelmedix's funding compare to other Biotechnology startups?
Gelmedix's latest round of $400k is below the $8.8M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.
About FundedIQ's Gelmedix Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Gelmedix is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.